Retrophin

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Retrophin and buy or sell other stocks, ETFs, and their options commission-free!

About RTRX

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. 

CEO
Eric M. Dube, PhD
CEOEric M. Dube, PhD
Employees
497
Employees497
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2008
Founded2008
Employees
497
Employees497

RTRX Key Statistics

Market cap
1.76B
Market cap1.76B
Price-Earnings ratio
-46.88
Price-Earnings ratio-46.88
Dividend yield
Dividend yield
Average volume
1.66M
Average volume1.66M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$42.13
52 Week high$42.13
52 Week low
$12.91
52 Week low$12.91

Stock Snapshot

With a market cap of 1.76B, Retrophin(RTRX) trades at $19.39. The stock has a price-to-earnings ratio of -46.88.

On 2026-03-03, Retrophin(RTRX) stock opened at —, reached a high of —, and a low of —.

The Retrophin(RTRX)'s current trading volume is 0, compared to an average daily volume of 1.66M.

In the last year, Retrophin(RTRX) shares hit a 52-week high of $42.13 and a 52-week low of $12.91.

In the last year, Retrophin(RTRX) shares hit a 52-week high of $42.13 and a 52-week low of $12.91.

People also own

Based on the portfolios of people who own RTRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.